Cyberonics
This article was originally published in The Gray Sheet
Executive Summary
Going public via initial public offering of 2 mil. shares of common stock at $12 per share. The Webster, Texas-based epilepsy device manufacturer plans to use proceeds from the sale for R&D efforts, expansion of sales and marketing activities and manufacturing capabilities, working capital and general corporate purposes. Morgan Stanley and Kidder, Peabody are underwriting.